Global Lung Cancer Liquid Biopsy Market Research Report 2023

Report ID: 2006980 | Published Date: Jan 2025 | No. of Page: 85 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Lung Cancer Liquid Biopsy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Exosomes and RNA
        1.2.3 CTCs and ctDNA
    1.3 Market by Application
        1.3.1 Global Lung Cancer Liquid Biopsy Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered
2 Global Growth Trends
    2.1 Global Lung Cancer Liquid Biopsy Market Perspective (2018-2029)
    2.2 Lung Cancer Liquid Biopsy Growth Trends by Region
        2.2.1 Global Lung Cancer Liquid Biopsy Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Lung Cancer Liquid Biopsy Historic Market Size by Region (2018-2023)
        2.2.3 Lung Cancer Liquid Biopsy Forecasted Market Size by Region (2024-2029)
    2.3 Lung Cancer Liquid Biopsy Market Dynamics
        2.3.1 Lung Cancer Liquid Biopsy Industry Trends
        2.3.2 Lung Cancer Liquid Biopsy Market Drivers
        2.3.3 Lung Cancer Liquid Biopsy Market Challenges
        2.3.4 Lung Cancer Liquid Biopsy Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Lung Cancer Liquid Biopsy Players by Revenue
        3.1.1 Global Top Lung Cancer Liquid Biopsy Players by Revenue (2018-2023)
        3.1.2 Global Lung Cancer Liquid Biopsy Revenue Market Share by Players (2018-2023)
    3.2 Global Lung Cancer Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Lung Cancer Liquid Biopsy Revenue
    3.4 Global Lung Cancer Liquid Biopsy Market Concentration Ratio
        3.4.1 Global Lung Cancer Liquid Biopsy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Liquid Biopsy Revenue in 2022
    3.5 Lung Cancer Liquid Biopsy Key Players Head office and Area Served
    3.6 Key Players Lung Cancer Liquid Biopsy Product Solution and Service
    3.7 Date of Enter into Lung Cancer Liquid Biopsy Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Lung Cancer Liquid Biopsy Breakdown Data by Type
    4.1 Global Lung Cancer Liquid Biopsy Historic Market Size by Type (2018-2023)
    4.2 Global Lung Cancer Liquid Biopsy Forecasted Market Size by Type (2024-2029)
5 Lung Cancer Liquid Biopsy Breakdown Data by Application
    5.1 Global Lung Cancer Liquid Biopsy Historic Market Size by Application (2018-2023)
    5.2 Global Lung Cancer Liquid Biopsy Forecasted Market Size by Application (2024-2029)
6 North America
    6.1 North America Lung Cancer Liquid Biopsy Market Size (2018-2029)
    6.2 North America Lung Cancer Liquid Biopsy Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Lung Cancer Liquid Biopsy Market Size by Country (2018-2023)
    6.4 North America Lung Cancer Liquid Biopsy Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada
7 Europe
    7.1 Europe Lung Cancer Liquid Biopsy Market Size (2018-2029)
    7.2 Europe Lung Cancer Liquid Biopsy Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Lung Cancer Liquid Biopsy Market Size by Country (2018-2023)
    7.4 Europe Lung Cancer Liquid Biopsy Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Lung Cancer Liquid Biopsy Market Size (2018-2029)
    8.2 Asia-Pacific Lung Cancer Liquid Biopsy Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Region (2018-2023)
    8.4 Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia
9 Latin America
    9.1 Latin America Lung Cancer Liquid Biopsy Market Size (2018-2029)
    9.2 Latin America Lung Cancer Liquid Biopsy Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Lung Cancer Liquid Biopsy Market Size by Country (2018-2023)
    9.4 Latin America Lung Cancer Liquid Biopsy Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Lung Cancer Liquid Biopsy Market Size (2018-2029)
    10.2 Middle East & Africa Lung Cancer Liquid Biopsy Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Country (2018-2023)
    10.4 Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE
11 Key Players Profiles
    11.1 RainDanceTechnologies
        11.1.1 RainDanceTechnologies Company Detail
        11.1.2 RainDanceTechnologies Business Overview
        11.1.3 RainDanceTechnologies Lung Cancer Liquid Biopsy Introduction
        11.1.4 RainDanceTechnologies Revenue in Lung Cancer Liquid Biopsy Business (2018-2023)
        11.1.5 RainDanceTechnologies Recent Development
    11.2 Biocartis
        11.2.1 Biocartis Company Detail
        11.2.2 Biocartis Business Overview
        11.2.3 Biocartis Lung Cancer Liquid Biopsy Introduction
        11.2.4 Biocartis Revenue in Lung Cancer Liquid Biopsy Business (2018-2023)
        11.2.5 Biocartis Recent Development
    11.3 Qiagen
        11.3.1 Qiagen Company Detail
        11.3.2 Qiagen Business Overview
        11.3.3 Qiagen Lung Cancer Liquid Biopsy Introduction
        11.3.4 Qiagen Revenue in Lung Cancer Liquid Biopsy Business (2018-2023)
        11.3.5 Qiagen Recent Development
    11.4 Guardant Health
        11.4.1 Guardant Health Company Detail
        11.4.2 Guardant Health Business Overview
        11.4.3 Guardant Health Lung Cancer Liquid Biopsy Introduction
        11.4.4 Guardant Health Revenue in Lung Cancer Liquid Biopsy Business (2018-2023)
        11.4.5 Guardant Health Recent Development
    11.5 MDxHealth
        11.5.1 MDxHealth Company Detail
        11.5.2 MDxHealth Business Overview
        11.5.3 MDxHealth Lung Cancer Liquid Biopsy Introduction
        11.5.4 MDxHealth Revenue in Lung Cancer Liquid Biopsy Business (2018-2023)
        11.5.5 MDxHealth Recent Development
    11.6 Pathway Genomics
        11.6.1 Pathway Genomics Company Detail
        11.6.2 Pathway Genomics Business Overview
        11.6.3 Pathway Genomics Lung Cancer Liquid Biopsy Introduction
        11.6.4 Pathway Genomics Revenue in Lung Cancer Liquid Biopsy Business (2018-2023)
        11.6.5 Pathway Genomics Recent Development
    11.7 NeoGenomics Laboraories
        11.7.1 NeoGenomics Laboraories Company Detail
        11.7.2 NeoGenomics Laboraories Business Overview
        11.7.3 NeoGenomics Laboraories Lung Cancer Liquid Biopsy Introduction
        11.7.4 NeoGenomics Laboraories Revenue in Lung Cancer Liquid Biopsy Business (2018-2023)
        11.7.5 NeoGenomics Laboraories Recent Development
    11.8 Sysmex Inostics
        11.8.1 Sysmex Inostics Company Detail
        11.8.2 Sysmex Inostics Business Overview
        11.8.3 Sysmex Inostics Lung Cancer Liquid Biopsy Introduction
        11.8.4 Sysmex Inostics Revenue in Lung Cancer Liquid Biopsy Business (2018-2023)
        11.8.5 Sysmex Inostics Recent Development
    11.9 Cynvenio
        11.9.1 Cynvenio Company Detail
        11.9.2 Cynvenio Business Overview
        11.9.3 Cynvenio Lung Cancer Liquid Biopsy Introduction
        11.9.4 Cynvenio Revenue in Lung Cancer Liquid Biopsy Business (2018-2023)
        11.9.5 Cynvenio Recent Development
    11.10 Menarini Silicon Biosystems
        11.10.1 Menarini Silicon Biosystems Company Detail
        11.10.2 Menarini Silicon Biosystems Business Overview
        11.10.3 Menarini Silicon Biosystems Lung Cancer Liquid Biopsy Introduction
        11.10.4 Menarini Silicon Biosystems Revenue in Lung Cancer Liquid Biopsy Business (2018-2023)
        11.10.5 Menarini Silicon Biosystems Recent Development
    11.11 Adaptive Biotechnologies
        11.11.1 Adaptive Biotechnologies Company Detail
        11.11.2 Adaptive Biotechnologies Business Overview
        11.11.3 Adaptive Biotechnologies Lung Cancer Liquid Biopsy Introduction
        11.11.4 Adaptive Biotechnologies Revenue in Lung Cancer Liquid Biopsy Business (2018-2023)
        11.11.5 Adaptive Biotechnologies Recent Development
    11.12 Biocept
        11.12.1 Biocept Company Detail
        11.12.2 Biocept Business Overview
        11.12.3 Biocept Lung Cancer Liquid Biopsy Introduction
        11.12.4 Biocept Revenue in Lung Cancer Liquid Biopsy Business (2018-2023)
        11.12.5 Biocept Recent Development
    11.13 Angle plc
        11.13.1 Angle plc Company Detail
        11.13.2 Angle plc Business Overview
        11.13.3 Angle plc Lung Cancer Liquid Biopsy Introduction
        11.13.4 Angle plc Revenue in Lung Cancer Liquid Biopsy Business (2018-2023)
        11.13.5 Angle plc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Lung Cancer Liquid Biopsy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Exosomes and RNA
    Table 3. Key Players of CTCs and ctDNA
    Table 4. Global Lung Cancer Liquid Biopsy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 5. Global Lung Cancer Liquid Biopsy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 6. Global Lung Cancer Liquid Biopsy Market Size by Region (2018-2023) & (US$ Million)
    Table 7. Global Lung Cancer Liquid Biopsy Market Share by Region (2018-2023)
    Table 8. Global Lung Cancer Liquid Biopsy Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 9. Global Lung Cancer Liquid Biopsy Market Share by Region (2024-2029)
    Table 10. Lung Cancer Liquid Biopsy Market Trends
    Table 11. Lung Cancer Liquid Biopsy Market Drivers
    Table 12. Lung Cancer Liquid Biopsy Market Challenges
    Table 13. Lung Cancer Liquid Biopsy Market Restraints
    Table 14. Global Lung Cancer Liquid Biopsy Revenue by Players (2018-2023) & (US$ Million)
    Table 15. Global Lung Cancer Liquid Biopsy Market Share by Players (2018-2023)
    Table 16. Global Top Lung Cancer Liquid Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Liquid Biopsy as of 2022)
    Table 17. Ranking of Global Top Lung Cancer Liquid Biopsy Companies by Revenue (US$ Million) in 2022
    Table 18. Global 5 Largest Players Market Share by Lung Cancer Liquid Biopsy Revenue (CR5 and HHI) & (2018-2023)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Lung Cancer Liquid Biopsy Product Solution and Service
    Table 21. Date of Enter into Lung Cancer Liquid Biopsy Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Lung Cancer Liquid Biopsy Market Size by Type (2018-2023) & (US$ Million)
    Table 24. Global Lung Cancer Liquid Biopsy Revenue Market Share by Type (2018-2023)
    Table 25. Global Lung Cancer Liquid Biopsy Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 26. Global Lung Cancer Liquid Biopsy Revenue Market Share by Type (2024-2029)
    Table 27. Global Lung Cancer Liquid Biopsy Market Size by Application (2018-2023) & (US$ Million)
    Table 28. Global Lung Cancer Liquid Biopsy Revenue Market Share by Application (2018-2023)
    Table 29. Global Lung Cancer Liquid Biopsy Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 30. Global Lung Cancer Liquid Biopsy Revenue Market Share by Application (2024-2029)
    Table 31. North America Lung Cancer Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 32. North America Lung Cancer Liquid Biopsy Market Size by Country (2018-2023) & (US$ Million)
    Table 33. North America Lung Cancer Liquid Biopsy Market Size by Country (2024-2029) & (US$ Million)
    Table 34. Europe Lung Cancer Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 35. Europe Lung Cancer Liquid Biopsy Market Size by Country (2018-2023) & (US$ Million)
    Table 36. Europe Lung Cancer Liquid Biopsy Market Size by Country (2024-2029) & (US$ Million)
    Table 37. Asia-Pacific Lung Cancer Liquid Biopsy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 38. Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Region (2018-2023) & (US$ Million)
    Table 39. Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Lung Cancer Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 41. Latin America Lung Cancer Liquid Biopsy Market Size by Country (2018-2023) & (US$ Million)
    Table 42. Latin America Lung Cancer Liquid Biopsy Market Size by Country (2024-2029) & (US$ Million)
    Table 43. Middle East & Africa Lung Cancer Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 44. Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Country (2018-2023) & (US$ Million)
    Table 45. Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Country (2024-2029) & (US$ Million)
    Table 46. RainDanceTechnologies Company Detail
    Table 47. RainDanceTechnologies Business Overview
    Table 48. RainDanceTechnologies Lung Cancer Liquid Biopsy Product
    Table 49. RainDanceTechnologies Revenue in Lung Cancer Liquid Biopsy Business (2018-2023) & (US$ Million)
    Table 50. RainDanceTechnologies Recent Development
    Table 51. Biocartis Company Detail
    Table 52. Biocartis Business Overview
    Table 53. Biocartis Lung Cancer Liquid Biopsy Product
    Table 54. Biocartis Revenue in Lung Cancer Liquid Biopsy Business (2018-2023) & (US$ Million)
    Table 55. Biocartis Recent Development
    Table 56. Qiagen Company Detail
    Table 57. Qiagen Business Overview
    Table 58. Qiagen Lung Cancer Liquid Biopsy Product
    Table 59. Qiagen Revenue in Lung Cancer Liquid Biopsy Business (2018-2023) & (US$ Million)
    Table 60. Qiagen Recent Development
    Table 61. Guardant Health Company Detail
    Table 62. Guardant Health Business Overview
    Table 63. Guardant Health Lung Cancer Liquid Biopsy Product
    Table 64. Guardant Health Revenue in Lung Cancer Liquid Biopsy Business (2018-2023) & (US$ Million)
    Table 65. Guardant Health Recent Development
    Table 66. MDxHealth Company Detail
    Table 67. MDxHealth Business Overview
    Table 68. MDxHealth Lung Cancer Liquid Biopsy Product
    Table 69. MDxHealth Revenue in Lung Cancer Liquid Biopsy Business (2018-2023) & (US$ Million)
    Table 70. MDxHealth Recent Development
    Table 71. Pathway Genomics Company Detail
    Table 72. Pathway Genomics Business Overview
    Table 73. Pathway Genomics Lung Cancer Liquid Biopsy Product
    Table 74. Pathway Genomics Revenue in Lung Cancer Liquid Biopsy Business (2018-2023) & (US$ Million)
    Table 75. Pathway Genomics Recent Development
    Table 76. NeoGenomics Laboraories Company Detail
    Table 77. NeoGenomics Laboraories Business Overview
    Table 78. NeoGenomics Laboraories Lung Cancer Liquid Biopsy Product
    Table 79. NeoGenomics Laboraories Revenue in Lung Cancer Liquid Biopsy Business (2018-2023) & (US$ Million)
    Table 80. NeoGenomics Laboraories Recent Development
    Table 81. Sysmex Inostics Company Detail
    Table 82. Sysmex Inostics Business Overview
    Table 83. Sysmex Inostics Lung Cancer Liquid Biopsy Product
    Table 84. Sysmex Inostics Revenue in Lung Cancer Liquid Biopsy Business (2018-2023) & (US$ Million)
    Table 85. Sysmex Inostics Recent Development
    Table 86. Cynvenio Company Detail
    Table 87. Cynvenio Business Overview
    Table 88. Cynvenio Lung Cancer Liquid Biopsy Product
    Table 89. Cynvenio Revenue in Lung Cancer Liquid Biopsy Business (2018-2023) & (US$ Million)
    Table 90. Cynvenio Recent Development
    Table 91. Menarini Silicon Biosystems Company Detail
    Table 92. Menarini Silicon Biosystems Business Overview
    Table 93. Menarini Silicon Biosystems Lung Cancer Liquid Biopsy Product
    Table 94. Menarini Silicon Biosystems Revenue in Lung Cancer Liquid Biopsy Business (2018-2023) & (US$ Million)
    Table 95. Menarini Silicon Biosystems Recent Development
    Table 96. Adaptive Biotechnologies Company Detail
    Table 97. Adaptive Biotechnologies Business Overview
    Table 98. Adaptive Biotechnologies Lung Cancer Liquid Biopsy Product
    Table 99. Adaptive Biotechnologies Revenue in Lung Cancer Liquid Biopsy Business (2018-2023) & (US$ Million)
    Table 100. Adaptive Biotechnologies Recent Development
    Table 101. Biocept Company Detail
    Table 102. Biocept Business Overview
    Table 103. Biocept Lung Cancer Liquid Biopsy Product
    Table 104. Biocept Revenue in Lung Cancer Liquid Biopsy Business (2018-2023) & (US$ Million)
    Table 105. Biocept Recent Development
    Table 106. Angle plc Company Detail
    Table 107. Angle plc Business Overview
    Table 108. Angle plc Lung Cancer Liquid Biopsy Product
    Table 109. Angle plc Revenue in Lung Cancer Liquid Biopsy Business (2018-2023) & (US$ Million)
    Table 110. Angle plc Recent Development
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Lung Cancer Liquid Biopsy Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Lung Cancer Liquid Biopsy Market Share by Type: 2022 VS 2029
    Figure 3. Exosomes and RNA Features
    Figure 4. CTCs and ctDNA Features
    Figure 5. Global Lung Cancer Liquid Biopsy Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 6. Global Lung Cancer Liquid Biopsy Market Share by Application: 2022 VS 2029
    Figure 7. Hospitals Case Studies
    Figure 8. Clinics Case Studies
    Figure 9. Others Case Studies
    Figure 10. Lung Cancer Liquid Biopsy Report Years Considered
    Figure 11. Global Lung Cancer Liquid Biopsy Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 12. Global Lung Cancer Liquid Biopsy Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 13. Global Lung Cancer Liquid Biopsy Market Share by Region: 2022 VS 2029
    Figure 14. Global Lung Cancer Liquid Biopsy Market Share by Players in 2022
    Figure 15. Global Top Lung Cancer Liquid Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Liquid Biopsy as of 2022)
    Figure 16. The Top 10 and 5 Players Market Share by Lung Cancer Liquid Biopsy Revenue in 2022
    Figure 17. North America Lung Cancer Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 18. North America Lung Cancer Liquid Biopsy Market Share by Country (2018-2029)
    Figure 19. United States Lung Cancer Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 20. Canada Lung Cancer Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. Europe Lung Cancer Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. Europe Lung Cancer Liquid Biopsy Market Share by Country (2018-2029)
    Figure 23. Germany Lung Cancer Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. France Lung Cancer Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. U.K. Lung Cancer Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. Italy Lung Cancer Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. Russia Lung Cancer Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Nordic Countries Lung Cancer Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Asia-Pacific Lung Cancer Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Asia-Pacific Lung Cancer Liquid Biopsy Market Share by Region (2018-2029)
    Figure 31. China Lung Cancer Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Japan Lung Cancer Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. South Korea Lung Cancer Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Southeast Asia Lung Cancer Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. India Lung Cancer Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. Australia Lung Cancer Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Latin America Lung Cancer Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Latin America Lung Cancer Liquid Biopsy Market Share by Country (2018-2029)
    Figure 39. Mexico Lung Cancer Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Brazil Lung Cancer Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Middle East & Africa Lung Cancer Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Middle East & Africa Lung Cancer Liquid Biopsy Market Share by Country (2018-2029)
    Figure 43. Turkey Lung Cancer Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Saudi Arabia Lung Cancer Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. RainDanceTechnologies Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2018-2023)
    Figure 46. Biocartis Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2018-2023)
    Figure 47. Qiagen Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2018-2023)
    Figure 48. Guardant Health Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2018-2023)
    Figure 49. MDxHealth Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2018-2023)
    Figure 50. Pathway Genomics Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2018-2023)
    Figure 51. NeoGenomics Laboraories Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2018-2023)
    Figure 52. Sysmex Inostics Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2018-2023)
    Figure 53. Cynvenio Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2018-2023)
    Figure 54. Menarini Silicon Biosystems Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2018-2023)
    Figure 55. Adaptive Biotechnologies Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2018-2023)
    Figure 56. Biocept Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2018-2023)
    Figure 57. Angle plc Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2018-2023)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
    Figure 60. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
RainDanceTechnologies
Biocartis
Qiagen
Guardant Health
MDxHealth
Pathway Genomics
NeoGenomics Laboraories
Sysmex Inostics
Cynvenio
Menarini Silicon Biosystems
Adaptive Biotechnologies
Biocept
Angle plc
Frequently Asked Questions
Lung Cancer Liquid Biopsy report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Lung Cancer Liquid Biopsy report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Lung Cancer Liquid Biopsy report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Lupus Therapeutic

This report aims to provide a comprehensive presentation of the global market for Lupus Therapeut ... Read More

Luxury Cars

This report aims to provide a comprehensive presentation of the global market for Luxury Cars, wi ... Read More